In the quest to discover, develop, and deliver innovative medicines, it has become increasingly important to form strategic partnerships and maximize their value.
Partnering is foundational to our history and instrumental to advancing bold science. With more than 25 years of experience since launching its first dedicated alliance management function in 1999, we're recognized as a leader in this field.
style
background-primary-red
additionalPadding
narrow
Diverse approaches solve the most complex scientific challenges, and we respect and value our partners’ experiences and perspectives. Our alliance managers keep alliance objectives and goals core to what they do, maximizing value and achieving more together. We accomplish this by focusing on the shared goals, synergies, and results generated from the alliance. The alliance manager is focused on resolving complex issues, aligning decisions, minimizing risks, and fostering transparency, respect, and trust.
We're dedicated to building strong and enduring relationships that generate groundbreaking medicines and fuel the highest level of innovation. Our vision is focused on driving long-term value for us and our strategic partners, which opens new horizons to improve health worldwide.
additionalPadding
narrow
Acquisitions integration
Integrating acquired companies is complex and involves the convergence of diverse organizational cultures, processes, technologies and people. As a result, the Acquisitions Transition Team is the hub to centralize processes to achieve excellence and consistency across acquisitions and the integration process. We are committed to preserving scientific value, maximizing employee experience, realizing synergies through partnership, and optimizing transparency and trust. By integrating these core principles, we aim to align our actions with our mission to advance our patient reach through strategic acquisitions.